Cianna picks up $10M to expand its cancer-fighting device

Aliso Viejo, CA's Cianna Medical has locked down a credit facility worth up to $10 million, cash the company will use to market its device designed to deliver radiation treatment to patients with early-stage breast cancer. The money comes courtesy of GE Capital, and Cianna said it will bankroll the U.S. and international commercialization of its SAVI device, a brachytherapy system that has been used to treat more than 20,000 women around the world. News

Suggested Articles

J&J’s Ethicon unit received an FDA clearance for its Vistaseal applicators that spray a biologic sealant from Grifols to help stem surgical bleeding.

Bio-Techne’s urine test has received a breakthrough device designation from the FDA for ruling out unnecessary tissue biopsies.

Qiagen launched a one-stop shop compiling publicly available genomic data, scientific literature and phenotypic information on potential superbugs.